tiprankstipranks
Trending News
More News >
Cidara Therapeutics (CDTX)
NASDAQ:CDTX
US Market
Advertisement

Cidara Therapeutics (CDTX) Technical Analysis

Compare
774 Followers

Technical Sentiment

Overall Consensus
Buy
14Bullish
1Neutral
7Bearish
Technical Analysis Consensus
Strong Sell
2Bullish
1Neutral
7Bearish
Moving Average Consensus
Strong Buy
12Bullish
0Neutral
0Bearish
Cidara Therapeutics’s (CDTX) Moving Averages Convergence Divergence (MACD) indicator is 7.29, suggesting Cidara Therapeutics is a Sell.
Cidara Therapeutics’s (CDTX) 20-Day exponential moving average is 52.41, while Cidara Therapeutics’s (CDTX) share price is $62.82, making it a Buy.
Cidara Therapeutics’s (CDTX) 50-Day exponential moving average is 41.27, while Cidara Therapeutics’s (CDTX) share price is $62.82, making it a Buy.

Cidara Therapeutics (CDTX) Pivot Points

Jul 26, 2025, 06:08 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
55.64
58.32
61.59
64.27
67.53
70.21
73.48
Fibonacci
58.32
60.59
61.99
64.27
66.54
67.94
70.21
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Cidara Therapeutics (CDTX) Moving Averages

Jul 26, 2025, 06:08 AM
Period
Simple
Exponential
MA5
61.24Buy
61.07Buy
MA10
57.20Buy
57.94Buy
MA20
53.22Buy
52.41Buy
MA50
36.83Buy
41.27Buy
MA100
28.81Buy
33.11Buy
MA200
23.74Buy
25.90Buy
Cidara Therapeutics’s (CDTX) 10-Day exponential moving average is 57.94, while Cidara Therapeutics’s (CDTX) share price is $62.82, making it a Buy.
Cidara Therapeutics’s (CDTX) 100-Day exponential moving average is 33.11, while Cidara Therapeutics’s (CDTX) share price is $62.82, making it a Buy.
Cidara Therapeutics’s (CDTX) stock price is $62.82 and Cidara Therapeutics’s (CDTX) 50-day simple moving average is 36.83, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $62.82 and Cidara Therapeutics’s (CDTX) 100-day simple moving average is 28.81, creating a Buy signal.
Cidara Therapeutics’s (CDTX) stock price is $62.82 and Cidara Therapeutics’s (CDTX) 200-day simple moving average is 23.74, creating a Buy signal.

Cidara Therapeutics (CDTX) Technical Indicators

Jul 26, 2025, 06:08 AM
Name
Value
Implied Action
RSI (14)
72.50
Sell
STOCH (9,6)
86.87
Sell
STOCHRSI (14)
89.11
Sell
MACD (12,26)
7.29
Sell
ADX (14)
58.17
Sell
Williams %R
-19.32
Sell
CCI (14)
164.14
Sell
ATR (14)
4.57
-
Ultimate Oscillator
69.06
Neutral
ROC
28.78
Buy
Cidara Therapeutics’s (CDTX) Relative Strength Index (RSI) is 72.50, creating a Sell signal.
Cidara Therapeutics’s (CDTX) Trend Strength Indicator (ADX) is 58.17, creating a Sell signal.
Cidara Therapeutics’s (CDTX) Commodity Channel Index (CCI) is 164.14, creating a Sell signal.
Cidara Therapeutics’s (CDTX) Price Rate of Change (ROC) is 28.78, creating a Buy signal.

FAQ

Is CDTX a Buy, Hold, or Sell?
Based on CDTX’s technical indicators, CDTX is a Buy.
    What is CDTX’s RSI (14)?
    CDTX’s RSI (14) is 72.50, which suggests CDTX is a Sell.
      What is CDTX’s MACD?
      CDTX’s MACD is 7.29, which suggests CDTX is a Sell.
        What is CDTX’s 5-day moving average?
        CDTX’s 5-day moving average is 61.24, which suggests CDTX is a Buy.
          What is CDTX’s 20-day moving average?
          CDTX 20-day moving average is 53.22, which suggests CDTX is a Buy.
            What is CDTX’s 50-day moving average?
            CDTX’s 50-day moving average is 36.83, which suggests CDTX is a Buy.
              What is CDTX’s 200-day moving average?
              CDTX’s 200-day moving average is 23.74, which suggests CDTX is a Buy.
                What is CDTX’s Williams % R (14)?
                CDTX’s Williams % R (14) is -19.32, which suggests CDTX is a Sell.
                  What is CDTX’s CCI (14)?
                  CDTX’s CCI (14) is 164.14, which suggests CDTX is a Sell.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis